crizotinib | |
---|---|
Trade Name | Xalkori |
Orphan Indication | Neuroblastoma |
USA Market Approval | USA |
USA Designation Date | 2012-10-31 00:00:00 |
Sponsor | Pfizer, Inc.;10646 Science Center Drive;San Diego, California, 92121 |
Related Access Program
South Plains Oncology Consortium – Recurrent Neuroblastoma
Catalyst Pharmaceuticals, Inc. – Downbeat Nystagmus
South Plains Oncology Consortium – Neuroblastoma
British Columbia Cancer Agency – Neuroblastoma
South Plains Oncology Consortium – Neuroblastoma
Children’s Hospital of Philadelphia – Neuroblastoma
University of California, San Francisco – Neuroblastoma
Jubilant DraxImage Inc. – Neuroblastoma
Children’s Hospital Medical Center, Cincinnati – Neuroblastoma
Apeiron Biologics AG – Neuroblastoma